Dissolved and financials
CVR: 37128899
DKK 0
Gross profit
Net result: DKK 0
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 18 January 2021
CVR · view overview
No headcount reported
Director role ended: Stoyanka Gospodinova Syarova-Vardina
CVR · 08/12/2020
View the full event history
PLANDALCELL IVS was a Danish company of the type Iværksætterselskab based in Horsens, founded in 2015. The company has been dissolved on 18 January 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 1.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201901/03/2018 – 28/02/2019 | 0 | 0 | 1 | 1 | - | |
| 201801/03/2017 – 28/02/2018 | 0 | 0 | 1 | 1 | - |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. PLANDALCELL IVS is registered in the Danish CVR register with the status Dissolved and ceased on 18 January 2021.
The CVR number of PLANDALCELL IVS is 37128899.
In 2019, PLANDALCELL IVS reported a gross profit of DKK 0.
PLANDALCELL IVS was founded on 3 October 2015.
PLANDALCELL IVS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
PLANDALCELL IVS was located at c/o Tanya- Stoyanka Syarova, Skolevænget 11, 8700 Horsens.
PLANDALCELL IVS was dissolved on January 18, 2021.
As of December 8, 2020, Stoyanka Gospodinova Syarova-Vardina has stepped down as director of PLANDALCELL IVS.
PLANDALCELL IVS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 0.
PLANDALCELL IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK 0.
PLANDALCELL IVS has published its interim report for the period October 3, 2015 to February 28, 2017.
As of February 18, 2018, Stoyanka Gospodinova Syarova-Vardina is registered as director of PLANDALCELL IVS.
As of December 9, 2017, Stoyanka Gospodinova Syarova-Vardina has stepped down as director of PLANDALCELL IVS.
As of October 3, 2015, Stoyanka Gospodinova Syarova-Vardina is registered as director of PLANDALCELL IVS.
PLANDALCELL IVS was founded on October 3, 2015.
